Role of Cefixime and Cefadroxil in Upper Respiratory Tract Infections
Cefixime in Upper Respiratory Tract Infections
- Cefixime is not recommended for upper respiratory tract infections due to its inactivity against pneumococci with decreased susceptibility to penicillin, while cefadroxil can be used as a first-line option for pharyngitis and tonsillitis caused by Streptococcus pyogenes 1
- Despite being a third-generation cephalosporin, cefixime is specifically not recommended for respiratory infections where pneumococci with decreased penicillin susceptibility are suspected due to its inactivity against these strains 1, 2
Cefadroxil in Upper Respiratory Tract Infections
- As a first-generation cephalosporin, cefadroxil can be used as a first-line antibiotic for exacerbations of chronic bronchitis when there are infrequent exacerbations 2
Treatment Algorithm for Upper Respiratory Tract Infections
- For maxillary sinusitis: Use amoxicillin-clavulanate, second-generation (cefuroxime-axetil) or specific third-generation cephalosporins (cefpodoxime-proxetil, cefotiam-hexetil) - NOT cefixime 3, 4
- For frontal, ethmoidal, or sphenoidal sinusitis: Consider fluoroquinolones active against pneumococci (levofloxacin, moxifloxacin) in addition to the above options 3, 5
- Duration of treatment: 7-10 days generally; cefuroxime-axetil and cefpodoxime-proxetil have shown efficacy in 5-day regimens 4
Important Clinical Considerations
- The increasing prevalence of bacterial resistance necessitates careful antibiotic selection 4
- Fluoroquinolones should be reserved for situations where major complications are likely or after first-line treatment failure 4
- Using cefixime for infections where pneumococci with decreased susceptibility to penicillin are suspected - this should be avoided 1, 2
- For otitis media in children under 2 years: Antibiotic therapy is recommended 1
- For children over 2 years: Antibiotics may be withheld except in cases with marked symptoms 1